An Evaluation of the Outcomes of Bariatric Surgery - a Cohort Study (ChirBar)

November 8, 2017 updated by: IHU Strasbourg

An Evaluation of the Outcomes of Bariatric Surgery - a Cohort Study Internal Hernia After Laparoscopic Roux-en-Y Gastric Bypass: an Evaluation of the Impact on the Postoperative Course and a Quality of Life Case-control Study

A prospective bariatric database was carried out in the Department of Digestive and Endocrine Surgery at the University Hospital of Strasbourg, France, starting in January 1996. All potential candidates for obesity surgery were prospectively registered in the database. Patients were informed by the bariatric surgeon of the prospective database, and of the possibility of utilizing personal data for research purpose after anonymization.

A case-control study was performed, to compare the quality of life (QoL) of patients treated for internal hernia (IH group) with the QoL of patients with an uncomplicated course after Roux en Y gastric bypass (Uncomplicated RYGB group).

Study Overview

Detailed Description

A prospective bariatric database was carried out in the Department of Digestive and Endocrine Surgery at the University Hospital of Strasbourg, France, starting in January 1996. All potential candidates for obesity surgery were prospectively registered in the database. Patients were informed by the bariatric surgeon of the prospective database, and of the possibility of utilizing personal data for research purpose after anonymization. Patients were evaluated by a multidisciplinary team. The standard preoperative assessment included nutritional counseling, psychological evaluation, abdominal ultrasound, upper gastrointestinal endoscopy, and blood tests. Type and date of surgery, biological and clinical follow-up data and morbidity data were recorded prospectively in the database.

A case-control study was performed, to compare the quality of life (QoL) of patients treated for internal hernia (IH group) with the QoL of patients with an uncomplicated course after Roux en Y gastric bypass (Uncomplicated RYGB group). Patients who had IH were paired with patients of the same age and sex and at the same postoperative interval. Paired patients were contacted by phone to obtain the QoL questionnaires, abdominal pain evaluation, and weight loss data.

Study Type

Observational

Enrollment (Anticipated)

10000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patient >18 years old BMI >35 kg/m²

Description

Inclusion Criteria:

  • patient >18 years old
  • BMI > 35 kg/m²

Exclusion Criteria:

  • Incapacity of giving an informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Excess weight loss
Time Frame: 1 - 3 - 5 - 10 - 15 and 30 years
1 - 3 - 5 - 10 - 15 and 30 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
BMI
Time Frame: 1 - 3 - 5 - 10 - 15 and 30 years
1 - 3 - 5 - 10 - 15 and 30 years
Albumin
Time Frame: 1 - 3 - 5 - 10 - 15 and 30 years
Albumin
1 - 3 - 5 - 10 - 15 and 30 years
Pre-albumin
Time Frame: 1 - 3 - 5 - 10 - 15 and 30 years
Pre-albumin
1 - 3 - 5 - 10 - 15 and 30 years
Vitamin A
Time Frame: 1 - 3 - 5 - 10 - 15 and 30 years
Vitamin A
1 - 3 - 5 - 10 - 15 and 30 years
Vitamin D
Time Frame: 1 - 3 - 5 - 10 - 15 and 30 years
Vitamin D
1 - 3 - 5 - 10 - 15 and 30 years
Vitamin B6
Time Frame: 1 - 3 - 5 - 10 - 15 and 30 years
Vitamin B6
1 - 3 - 5 - 10 - 15 and 30 years
Vitamin B9
Time Frame: 1 - 3 - 5 - 10 - 15 and 30 years
Vitamin B9
1 - 3 - 5 - 10 - 15 and 30 years
Vitamin B12
Time Frame: 1 - 3 - 5 - 10 - 15 and 30 years
Vitamin B12
1 - 3 - 5 - 10 - 15 and 30 years
Plasma ferritin
Time Frame: 1 - 3 - 5 - 10 - 15 and 30 years
Plasma ferritin
1 - 3 - 5 - 10 - 15 and 30 years
Fasting plasma glucose
Time Frame: 1 - 3 - 5 - 10 - 15 and 30 years
Fasting plasma glucose
1 - 3 - 5 - 10 - 15 and 30 years
Serum insulin
Time Frame: 1 - 3 - 5 - 10 - 15 and 30 years
Serum insulin
1 - 3 - 5 - 10 - 15 and 30 years
HbA1c
Time Frame: 1 - 3 - 5 - 10 - 15 and 30 years
HbA1c
1 - 3 - 5 - 10 - 15 and 30 years
Triglycerides
Time Frame: 1 - 3 - 5 - 10 - 15 and 30 years
Triglycerides
1 - 3 - 5 - 10 - 15 and 30 years
Cholesterol
Time Frame: 1 - 3 - 5 - 10 - 15 and 30 years
Cholesterol (total, HDL, LDL)
1 - 3 - 5 - 10 - 15 and 30 years
Quality of life assessed by Moorehead-Ardelt Quality of life II questionnaire
Time Frame: 1 - 3 - 5 - 10 - 15 and 30 years
Moorehead-Ardelt Quality of life II questionnaire
1 - 3 - 5 - 10 - 15 and 30 years
Quality of life assessed by Gastro-intestinal Quality of Life Index
Time Frame: 1 - 3 - 5 - 10 - 15 and 30 years
Gastro-intestinal Quality of Life Index
1 - 3 - 5 - 10 - 15 and 30 years
Postoperative morbidity
Time Frame: 1 - 3 - 5 - 10 - 15 and 30 years
Postoperative morbidity
1 - 3 - 5 - 10 - 15 and 30 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Didier Mutter, MD, PhD, Department of Digestive and Endocrine Surgery, University Hospital of Strasbourg

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 1996

Primary Completion (Anticipated)

December 1, 2026

Study Completion (Anticipated)

December 1, 2026

Study Registration Dates

First Submitted

June 13, 2016

First Submitted That Met QC Criteria

June 21, 2016

First Posted (Estimate)

June 23, 2016

Study Record Updates

Last Update Posted (Actual)

November 9, 2017

Last Update Submitted That Met QC Criteria

November 8, 2017

Last Verified

November 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Morbid Obesity

Clinical Trials on Roux en Y gastric bypass

Subscribe